Total Assets: The sum of all assets on a company's balance sheet.
Zenas BioPharma, Inc. (ZBIO) had Total Assets of $383.64M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-240.44M |
|
-- |
|
-- |
|
$237.98M |
|
$-237.98M |
|
$-2.35M |
|
$-240.34M |
|
$-240.34M |
|
$-240.44M |
|
$-240.44M |
|
$-240.44M |
|
$-240.44M |
|
$-237.98M |
|
$-237.97M |
|
44.73M |
|
44.73M |
|
$-5.17 |
|
$-5.17 |
|
| Balance Sheet Financials | |
$351.17M |
|
$0.03M |
|
$32.47M |
|
|
Total Assets |
$383.64M |
$62.65M |
|
$78.64M |
|
$78.85M |
|
$141.50M |
|
$242.14M |
|
$242.14M |
|
$242.14M |
|
54.49M |
|
| Cash Flow Statement Financials | |
$-172.33M |
|
$-251.89M |
|
$215.28M |
|
$319.83M |
|
$110.64M |
|
$-209.19M |
|
$26.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.61 |
|
-- |
|
-- |
|
0.25 |
|
0.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-172.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-99.30% |
|
-99.30% |
|
-62.67% |
|
-74.96% |
|
$4.44 |
|
$-3.85 |
|
$-3.85 |
|